COA At-a-Glance
Evidence of cognitive interviewing of draft instrument in target patient population
Evidence of internal consistency
Evidence of test-retest or inter-rater reliability
Evidence of concurrent validity
Evidence of known-groups validity
Evidence of ability to detect change over time
Evidence of responder thresholds
Inclusion of the COA in product labelling
- Overview
- Content Validity
- Reliability
- Validity
- Ability to Detect Change
- Responder Thresholds
- Reference(s) of development / validation
- Other references
- Inclusion of the COA in product labelling
- Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
- Existence of Scoring / Interpretation / User Manual
- Original language and translations
- References of translations
- Authors and contact information
- Condition of use: copyright
- Website
- Review copy
Overview
Instrument Name: Youth Self Rating Insomnia Scale
Abbreviation: YSIS
Points for Consideration:
None
Description of Tool:
The Youth Self Rating Insomnia Scale (YSIS) is an 8-item PRO developed to measure insomnia severity for adolescents. The YSIS consists of questions that ask about insomnia symptoms and waking symptoms or daytime consequences. Respondents are asked to rate each question on a 5-level scale ranging from 1 to 5 with varying response categories across items including "Very good" to "Very poor" (sleep quality), "Very good" to "Very poor" (sleep satisfaction) and "Never", "Rarely (< 1 time/week),""Sometimes (1-2 times/week)", "Often (3-5 times/week" to "Always every day (6-7 times/week" . Higher scores indicate greater insomnia severity within the past month.
Other Related Tools (if applicable):
The YSIS was developed based on the Sleep Habits Survey, Child Sleep Habits Questionnaire, Pediatric Sleep Questionnaire, Insomnia Severity Index, Athens Insomnia Scale and Pittsburgh Sleep Quality Index
Minimum Qualification Required by COA Administrator: No degree requirement
Comment:
None
Year: 2019
Objective of Development:
To measure insomnia severity for adolescents
Population of Development: Age range (therapeutic indication):
Mean age: 15 years (SD=1.5) (No therapeutic indication)
Pediatric Population(s) in which COA has been used:
None identified
COA type: PRO
Number of Items 8
Mode of Administration: Self-administered
Data Collection Mode: Pen and paper administration
Time for Completion: No information
Response Scales: 5-point Likert scale ranging from 1 to 5. The YSIS has varying response categories across items: Item 1 (sleep quality): 1="Very good" to 5="Very poor" Item 2 (sleep satisfaction): 1="Very satisfied" to 5="Very unsatisfied" Items 3-6: 1="Never", 2="Rarely (< 1 time/week),", 3="Sometimes (1-2 times/week)", 4="Often (3-5 times/week", 5="Always every day (6-7 times/week"
Summary of Scoring:
Available scores: Total score ranging from 8 to 40
Weighting: No
Score Interpretation: Higher scores=Higher insomnia severity
Content Validity
Evidence of Literature Review: None identified
Evidence of Instrument Review: None identified
Evidence of Clinical or Expert Input: None identified
Evidence of concept elicitation in target patient population: None identified
Evidence of a Saturation Grid: None identified
Evidence for Selection of Data Collection Method: None identified
Recall/Observation Period: Past month
Evidence for Selection of Reponse Options: Yes
Evidence of cognitive interviewing of draft instrument in target patient population: None identified
Evidence of Preliminary Scoring of Items and Domains: None identified
Evidence related to respondent and administrator burden: None identified
Evidence of a Conceptual Framework: None identified
Evidence of an item-tracking matrix: None identified
Evidence related to item selection: None identified
Evidence of re-testing the final version: None identified
Reliability
Internal consistency (Cronbach's alpha): Yes
Evidence of internal consistency: Liu X (2019) - Method: Coefficient omega Cronbach's alpha -Results: Coefficient omega: 0.82 Cronbach's alpha: 0.80 Population/Disease: Adolescents (mean age 15 years) from middle and high schools; n=11,836
Test-retest Reliability (ICC):
Liu X (2019)
Test-retest reliability
- ICC: Total YSIS score 0.90, ranging from 0.41-0.75 for individual items
- Was a definition of stability applied to identify stable patients: Not stated
- Time frame between the two administrations: 2 weeks
- Population/Disease: Adolescents (mean age 14.7 years) from middle and high schools; n=242
Inter-rater/ inter-interviewer reliability (kappa):
None identified
Evidence of test-retest or inter-rater reliability: Yes
Validity
Concurrent validity (convergent, divergent):
None identified
Known-group validity:
None identified
Evidence of Translatability Assessment: Yes
Evidence related to missing data: None identified
Evidence for Selection of Recall Period: None identified
Evidence of Administration Instructions and Training Provided: Yes
Evidence of concurrent validity: None identified
Evidence of known-groups validity: None identified
Evidence of ability to detect change over time: None identified
Ability to Detect Change
Ability to detect change (Responsiveness):
None identified
Responder Thresholds
Responder Thresholds:
None identified
Evidence of responder thresholds: None identified
Reference(s) of development / validation
Liu, X., Yang, Y., Liu, ZZ. et al. Psychometric properties of Youth Self-Rating Insomnia Scale (YSIS) in Chinese adolescents. Sleep Biol. Rhythms 17, 339–348 (2019). Full Text Article: https://link.springer.com/article/10.1007/s41105-019-00222-3#citeas
Other references
None identified
Inclusion of the COA in product labelling
None identified
Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
None identified
Existence of Scoring / Interpretation / User Manual
Yes
Original language and translations
Original language: English
Translations: Chinese
References of translations
None identified
Condition of use: copyright
None identified
Website
None identified
Review copy
https://pmc.ncbi.nlm.nih.gov/articles/PMC10900025/